The first wireless ionization chamber array for particle therapy PSQA delivers fast, reliable verification for proton and carbon ion treatments, supporting emerging techniques such as FLASH and ARC radiotherapy. Louvain-la-Neuve, Belgium, 21 March 2026 – IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and a global provider of dosimetry and quality assurance (QA) solutions, announces the launch of myQA MatriXX AiR, a high resolution, wireless 2D ionization chamber array designed for patient specific quality assurance (PSQA) in particle therapy, including proton and carbon ion treatments. This new solution further demonstrates IBA’s role as a driving force in innovation and reinforces its leadership in quality assurance for particle‑beam therapies. In radiation therapy, quality assurance is...

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC: MECPF, FRA: 92T) (“Mustang” or the “Company”) announces that, further to its News Releases of October 9, 2025 and November 27, 2025, it is proceeding to complete its previously announced plan of arrangement (the “Arrangement”) to be effected under Part 9, Division 5 of the Business Corporations Act (British Columbia) (the “BCBCA”) with its wholly-owned subsidiary, Allied Strategic Resource Corp. (“Allied”). On October 14, 2025, the Company obtained an interim order from the British Columbia Supreme Court (the “Court”) authorizing the Company to call a shareholder’s meeting to, among other things, approve the Arrangement. Shareholders...

GRAND CAYMAN, Cayman Islands, March 20, 2026 (GLOBE NEWSWIRE) — Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the “Company”), which together with its subsidiaries is engaged in the business of tokenized Real-World Assets (“RWAs”), initially in the form of tokenized reinsurance securities, and reinsurance business solutions to property and casualty today, announced that it plans to hold a conference call on Monday March 30, 2026 at 4:30 p.m. Eastern time to discuss results for the fourth quarter and year ending December 31, 2025. Financial results will be issued in a press release after the close of the market on the same day. Oxbridge Re’s management will host the conference call, followed by a question and answer period. Interested parties can listen to the live presentation by dialing the listen-only number below.Date: March...

THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, March 20, 2026 (GLOBE NEWSWIRE) — Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), is pleased to announce that it has closed an initial tranche (“First Tranche”) of the offering announced on March 10, 2026 and March 11, 2026 (collectively, the “Announcement NRs”) and has issued 3,750 Debenture Units (as defined in the Announcement NRs) for $3,750,000. The Company will use the proceeds from the First Tranche for the ongoing development of the Company’s business model and for general working capital purposes. One director of the Company (the “Director Subscriber”) participated in the Offering (as...

The proposed business combination was initially announced on July 8, 2025. NEW YORK, March 20, 2026 (GLOBE NEWSWIRE) — ReserveOne, Inc. (“ReserveOne”) and ReserveOne Holdings, Inc. (“Pubco”) today announced that, in connection with the previously disclosed proposed business combination with M3-Brigade Acquisition V Corp. (NASDAQ: MBAVU, MBAV, MBAVW) (“M3-Brigade”), Pubco has publicly filed a second amendment to the registration statement on Form S-4 (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”). This second amendment follows Pubco’s previous public filings of the Registration Statement on December 5, 2025, and the first amendment filed on February 17, 2026, and reflects continued progress in the SEC review process. Subject...

Not for distribution to United States newswire services or for dissemination in the United States. VANCOUVER, BC, March 20, 2026 (GLOBE NEWSWIRE) — Fobi AI Inc. (TSXV:FOBI) (Pink: FOBIF) (the “Company” or “Fobi“), an industry leader in harnessing AI and data intelligence to enable digital transformation, is pleased to announce the completion of its third tranche closing effective March 19, 2026 (the “Third Tranche”) of a non-brokered private placement financing previously announced on December 12, 2025 (the “Offering”) (and with the first and second tranche closings completed and announced on January 23, 2026 and February 3, 2026, respectively) therefore completing the Offering of 27,084,000 units of the Company (“Units“) at a price per Unit of $0.05 for aggregate gross proceeds of $1,354,200.00. The...

VANCOUVER, British Columbia, March 20, 2026 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN, FSE: 85W0, OTC PINK: HYTNF) (“HYTN” or the “Company”), a pharmaceutical manufacturer specializing in cannabis, is pleased to announce the appointment of Mr. Fabian Monaco to its Board of Directors, effective immediately. Mr. Monaco is an accomplished technology entrepreneur, investor, and operator with a proven history of building and scaling high-growth businesses. He brings extensive experience across venture capital, private equity, and public markets, with a focus on software, fintech, and platform-based companies. Mr. Monaco is the owner of Giumar Capital Inc., a boutique investment banking and advisory practice. He is also the co-founder and former Chief Executive Officer of Gage Growth Corp., which was acquired by TerrAscend Corp....

Toronto, March 20, 2026 (GLOBE NEWSWIRE) — DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on March 18, 2026 issuing 4,360,000 units (the “Units”) at a subscription price of C$0.05 per Unit, for gross proceeds of C$218,000 (“the Offering”). Each Unit consists of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”). Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance. Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one...

ATHENS, Greece, March 20, 2026 (GLOBE NEWSWIRE) — Global Ship Lease, Inc. (NYSE:GSL) (the “Company”), a containership owner and lessor, filed its Annual Report on Form 20-F for the year ended December 31, 2025 (the “Form 20-F”) with the U.S. Securities and Exchange Commission (the “SEC”). In compliance with the New York Stock Exchange rules, a copy of the Form 20-F can be found under the Investor Relations section (Annual Reports) of the Company’s website at http://www.globalshiplease.com. Shareholders may request a hard copy of the audited financial statements free of charge by contacting the Company at info@globalshiplease.com or by writing to Global Ship Lease, Inc., care of GSL Enterprises Ltd., 9 Irodou Attikou Street, Athens, 145 61, Greece or by telephoning IGB Group at +1-646-673-9701. About...